The Lancet. Respiratory medicine

A standard set of outcomes for adults with post-COVID-19 condition for clinical practice and research.

Updated

Abstract

A total of 1,535 participants from 71 countries contributed to defining key health outcomes for post-COVID-19 condition.

  • Consensus was reached on 11 important health outcomes for post-COVID-19 condition, including fatigue and pain.
  • Other agreed outcomes include post-exertion symptoms, changes in work or study, survival, and various functional and symptom measures.
  • Specific areas of focus for outcomes cover cardiovascular, respiratory, nervous system, cognitive, mental health, and physical aspects.
  • Recovery was included due to its relevance from a previously established outcome set.
  • The next phase involves selecting the best tools to measure these core outcomes.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Declaration of interests DM is a co-chair of the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) Global Paediatric Long COVID working group and a member of the ISARIC working group on long-term follow-up in adults. CA reports grants or contracts from Dr Wolff Group, Bionorica, and The European Cooperation in Science and Technology; consulting fees from the Dr Wolff Group, Bionorica, and Sanofi-Aventis Germany; and honoraria from AstraZeneca. SLG is the project coordinator of the Core Outcome Measures in Effectiveness Trials (COMET) Initiative. PRW is chair of the COMET Management Group. All other authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free